Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Non-Current Debt (2021 - 2023)

Historic Non-Current Debt for Standard Biotools (LAB) over the last 5 years, with Q4 2023 value amounting to $3.4 million.

  • Standard Biotools' Non-Current Debt fell 5833.54% to $3.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $3.4 million, marking a year-over-year decrease of 5833.54%. This contributed to the annual value of $3.4 million for FY2023, which is 5833.54% down from last year.
  • As of Q4 2023, Standard Biotools' Non-Current Debt stood at $3.4 million, which was down 5833.54% from $4.6 million recorded in Q3 2023.
  • In the past 5 years, Standard Biotools' Non-Current Debt registered a high of $10.2 million during Q2 2022, and its lowest value of $3.4 million during Q4 2023.
  • Its 3-year average for Non-Current Debt is $7.9 million, with a median of $8.8 million in 2022.
  • Per our database at Business Quant, Standard Biotools' Non-Current Debt plummeted by 614.0% in 2022 and then plummeted by 5833.54% in 2023.
  • Standard Biotools' Non-Current Debt (Quarter) stood at $10.0 million in 2021, then dropped by 18.46% to $8.2 million in 2022, then plummeted by 58.34% to $3.4 million in 2023.
  • Its Non-Current Debt stands at $3.4 million for Q4 2023, versus $4.6 million for Q3 2023 and $5.8 million for Q2 2023.